Back to SYRE
BANK OF AMERICA CORP /DE/ → SYRE
BANK OF AMERICA CORP /DE/ SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$6.3M
Q3 2026
Peak value
$153.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $5.6M |
| Q3 2025 | $137K |
| Q3 2025 | $17 |
| Q4 2025 | $12.4M |
| Q4 2025 | $1.3M |
| Q4 2025 | $33 |
| Q1 2026 | $61.3M |
| Q1 2026 | $619K |
| Q2 2026 | $153.2M |
| Q2 2026 | $3.6M |
| Q2 2026 | $1.1M |
| Q3 2026 | $148.3M |
| Q3 2026 | $3.9M |
| Q3 2026 | $4.3M |
| Q3 2026 | $6.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $6.3M | 71.3K | — | — |
| Q3 2026 | $4.3M | 48.5K | — | — |
| Q3 2026 | $3.9M | 43.9K | — | — |
| Q3 2026 | $148.3M | 1.67M | — | — |
| Q2 2026 | $1.1M | 12.1K | — | — |
| Q2 2026 | $3.6M | 40.3K | — | — |
| Q2 2026 | $153.2M | 1.73M | — | — |
| Q1 2026 | $619K | 12.3K | — | — |
| Q1 2026 | $61.3M | 1.22M | — | — |
| Q4 2025 | $33 | 1 | — | — |
| Q4 2025 | $1.3M | 40.6K | — | — |
| Q4 2025 | $12.4M | 379.2K | — | — |
| Q3 2025 | $17 | 1 | — | — |
| Q3 2025 | $137K | 8.2K | — | — |
| Q3 2025 | $5.6M | 336.6K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M